Intraperitoneal insulin administration does not modify plasminogen activator inhibitor 1 levels in IDDM patients.
Raccah
D
D
Lassmann-Vague
V
V
Alessi
M C
MC
Juhan-Vague
I
I
Vague
P
P
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*
D001786:Blood Glucose; D007328:Insulin; D017395:Plasminogen Activator Inhibitor 1